Compare NEO & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEO | ESRT |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 994.9M |
| IPO Year | 2008 | 2012 |
| Metric | NEO | ESRT |
|---|---|---|
| Price | $13.88 | $5.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $13.38 | $6.35 |
| AVG Volume (30 Days) | ★ 3.0M | 1.7M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $768,270,000.00 |
| Revenue This Year | $10.63 | $4.26 |
| Revenue Next Year | $9.73 | $1.52 |
| P/E Ratio | ★ N/A | $546.00 |
| Revenue Growth | N/A | ★ 0.05 |
| 52 Week Low | $4.72 | $4.87 |
| 52 Week High | $15.57 | $8.07 |
| Indicator | NEO | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 56.16 |
| Support Level | $13.80 | $5.23 |
| Resistance Level | $15.31 | $5.83 |
| Average True Range (ATR) | 0.68 | 0.17 |
| MACD | -0.21 | 0.00 |
| Stochastic Oscillator | 24.08 | 59.09 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.